Biotechs fare relatively well amidst share collapse
Interviewee/Contributor
William Ellington
Organisation
MedNous
Research Directory
COVID-19's logistical impact on advanced therapies
Interviewee/ContributorMatthew LakelinOrganisationTrakCel LtdSolving the viral vector bottleneck during a pandemic
Interviewee/ContributorGéraldine Guérin-PeyrouOrganisationPolyplus-transfection SAWhat patients really want: involvement
Interviewee/ContributorPierre MeulienOrganisationInnovative Medicines InitiativeScientists and industry mobilise against coronavirus
Interviewee/ContributorVictoria EnglishOrganisationMedNousLate-stage oncology pipeline is robust
Interviewee/ContributorBruno PagliaraOrganisationMedNousA meeting of minds at AstraZeneca
Interviewee/ContributorJosé BaselgaOrganisationAstraZeneca PlcGroundbreaking genomic study of cancer published
Interviewee/ContributorPeter CharlishOrganisationMedNousInterview: The metabolic route to drug discovery
Interviewee/ContributorDavid MollerOrganisationPoxel SAInterview: Targeting diseases of cortisol deficiency
Interviewee/ContributorMartin WhitakerOrganisationDiurnal Group Plc